John Lunger's Insider Trades & SAST Disclosures

John Lunger's most recent trade in Adaptimmune Therapeutics Plc - ADR was a trade of 1,612,032 Option to purchase Ordinary Shares done . Disclosure was reported to the exchange on Feb. 20, 2025.

Share

Note

This is a custom search result for pattern John Lunger.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Adaptimmune Therapeutics Plc 10-year low	John Lunger	Chief Patient Supply Officer		20 Feb 2025	1,612,032	1,612,032	-		-	Option to purchase Ordinary Shares
Adaptimmune Therapeutics Plc 10-year low	John Lunger	Chief Patient Supply Officer		20 Feb 2025	1,074,696	1,074,696	-		-	Option to purchase Ordinary Shares
Adaptimmune Therapeutics Plc 10-year low	John Lunger	Chief Patient Supply Officer		17 Jan 2025	5,584	7,510 (0%)	0%	0.6	3,243	American Depositary Shares representing Ordinary Shares
Adaptimmune Therapeutics Plc 10-year low	John Lunger	Chief Patient Supply Officer		13 Jan 2025	9,803	13,756 (0%)	0%	0.6	5,635	American Depositary Shares representing Ordinary Shares
Adaptimmune Therapeutics Plc 10-year low	John Lunger	Chief Patient Supply Officer		13 Jan 2025	5,471	7,623 (0%)	0%	0.6	3,216	American Depositary Shares representing Ordinary Shares
Adaptimmune Therapeutics Plc 10-year low	John Lunger	Chief Patient Supply Officer		13 Jan 2025	4,268	5,845 (0%)	0%	0.6	2,509	American Depositary Shares representing Ordinary Shares
Adaptimmune Therapeutics Plc 10-year low	John Lunger	Chief Patient Supply Officer		16 Jan 2024	12,805	19,015 (0%)	0%	0.7	8,618	American Depositary Shares representing Ordinary Shares
Adaptimmune Therapeutics Plc 10-year low	John Lunger	Chief Patient Supply Officer		16 Jan 2024	5,309	7,785 (0%)	0%	0.7	3,573	American Depositary Shares representing Ordinary Shares
Adaptimmune Therapeutics Plc 10-year low	John Lunger	Chief Patient Supply Officer		16 Jan 2024	4,681	7,023 (0%)	0%	0.8	3,698	American Depositary Shares representing Ordinary Shares
Adaptimmune Therapeutics Plc 10-year low	John Lunger	Chief Patient Supply Officer		15 Jan 2024	2,544,432	2,544,432	-		-	Option to purchase Ordinary Shares
Adaptimmune Therapeutics Plc 10-year low	John Lunger	Chief Patient Supply Officer		15 Jan 2024	565,416	565,416	-		-	Option to purchase Ordinary Shares
Adaptimmune Therapeutics Plc 10-year low	John Lunger	Chief Patient Supply Officer		11 Jan 2024	5,220	7,874 (0%)	0%	0.9	4,458	American Depositary Shares representing Ordinary Shares
Adaptimmune Therapeutics Plc 10-year low	John Lunger	Chief Patient Supply Officer		11 Jan 2024	4,009	6,104 (0%)	0%	0.8	3,354	American Depositary Shares representing Ordinary Shares

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades